Peri-Implant Soft Tissue Integration in Humans: Influence of Material
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy Subjects
- Sponsor
- Centre Hospitalier Universitaire de Liege
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Histomorphometry
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to compare the mucointegration of 2 types of surface roughness of zirconia abutments with titanium. The surface roughness will be machined and ultra-polished.
Detailed Description
After being informed about the study and potential risks, all participants give written informed consent and eligibility for study entry. The day of the surgery, patients will be randomized in machined zirconia or ultra-polished zirconia. After 8 weeks of healing, biopsy are separated in two groups according to the removal: * if the abutment come together with the surrounding soft tissues, it goes for a non decalcified histology for histometric measurements to determine the dimensions of biological width (sulcus depth, epithelial and connective adhesion) * if the abutment come separate of the surrounding tissue, the soft tissue goes for immunohistochemistry to analyse pro-inflammatory cells and vascularisation and the abutment for SEM analysis to calculate the percentage of adhesion of the cells on the abutment
Investigators
Clémentine CANUEL
2nd year resident in periodontology, oral and implant surgery
Centre Hospitalier Universitaire de Liege
Eligibility Criteria
Inclusion Criteria
- •Participants have to voluntarily sign the informed consent form before any study related action
- •Patients aged 18 or over
- •Patients with one or more missing teeth in the maxillary or mandible area, seeking implant therapy
- •Men/women
- •Patients in good systemic health (ASA I/ II) and no contraindication for oral surgical interventions
- •Patients requiring a replacement of missing teeth; the tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation
- •At least 3 mm of fibrous mucosa in the bucco-lingual dimension
- •Full mouth plaque score (FMPI) lower than or equal to 25%
- •At least a diameter of 4 mm for the implant (regular diameter)
Exclusion Criteria
- •Autoimmune disease requiring medical treatment
- •Medical conditions requiring prolonged use of steroids
- •Use of Bisphosphonates intravenously or more than 3 years of oral use
- •Infection (local or systemic) - patients with gingivitis or active local infection will undergo a medical treatment prior to the entrance to the study, and each individual will be evaluated for suitability; in case of a systemic infection, the evaluation will be based on medical anamneses, and if necessary, a patient will be referred to relevant medical tests
- •Current pregnancy or breastfeeding women
- •Alcoholism or chronical drug abuse
- •Immunocompromised patients
- •Uncontrolled diabetes
- •Prisoners
- •Implant's diameter under 4 mm (narrow implant)
Outcomes
Primary Outcomes
Histomorphometry
Time Frame: 8 weeks of healing
Height measure of biological width (sulcus depth, epithelial and connective adhesion)
Immunohistology
Time Frame: 8 weeks of healing
Analysis of the pro-inflammatory cells and vascularisation of the soft tissue + analysis of the percentage of cells adhesion on the abutment